CBD represents a solid market opportunity for DME pharmacies, but work needs to be done. Fortunately, we're getting there.
How to approach the CGS/Noridian letter and the '60-Day Rule.'
Each October we ask the members of HMEB’s editorial advisory board to share their insights into the trends, obstacles, challenges and opportunities that providers will likely encounter over the next several months. This year, the board members are pointing to several developments that providers might not have on their radars.
The proposed rule includes a lot of positives, but experts have pointed out some notable issues.
This webinar will set out concrete steps that the DME supplier can take to avoid fraud landmines in the first place, and take remedial steps if the supplier discovers that it may have engaged in fraudulent actions.
Contact your State and National Organizations.
HME Business' free email newsletter keeping you up-to-date and informed.
Contact the Editor.